En Es
Categories

Industry News

Intelerad Acquires Life Image to Create World’s Largest Medical Image Exchange Network

By Medimaging International staff writers
16 Sep 2022

Image: The acquisition combines two leading image exchange providers, managing 80 billion images globally (Photo courtesy of Life Image)

Intelerad Medical Systems (Raleigh, NC, USA), a leading global provider of enterprise imaging solutions, has acquired Life Image (Newton, MA, USA), one of the largest image exchange networks of curated clinical and imaging data, creating the largest medical image exchange network in the world and laying the groundwork for the elimination of costly CDs as the primary means of image transfer.


Medical record interoperability has been a key component of the 21st Century Cures Act and its focus on eliminating all forms of information blocking. Radiology leaders and industry stakeholders have been champions for establishing a framework for seamless electronic image transfer in an effort to improve patient care and eliminate the burden on caregivers. By combining two of the largest image sharing networks and ensuring open access between networks, Intelerad takes a critical step in advancing access to digital health information.


Leading healthcare systems have been pushing for seamless interoperability. With this transaction, Intelerad and Life Image serve many of the largest medical institutions in the world, including Mayo Clinic, Cleveland Clinic and New York Presbyterian Hospital. The combined network manages over 80 billion images globally, enabling 24/7 digital image sharing from any device wherever the provider or patient may be.


“As a company, Intelerad has been unwavering in backing the challenge put forth by the American College of Radiology (ACR), RSNA and SIIM to #ditchthedisk. Today’s transaction reflects one of the most important steps we could imagine in reaching that vision,” said Mike Lipps, Intelerad CEO. “Bringing together two of the industry’s leading image exchange providers further solidifies Intelerad’s commitment to helping clinicians and patients lead the revolution in imaging from a world of siloed PACS to a future of interoperable image exchange.”


“Together we have both worked to advance patient care and are excited to have the opportunity to bring these two leading networks together to advance interoperability,” said Morris Panner, President of Intelerad and former CEO of Ambra Health, which was acquired by Intelerad in October 2021. “As independent companies we competed, but also pioneered some of the most important cross-vendor exchanges in the industry. By combining, we are able to advance our vision and technology more rapidly and achieve our joint vision of a true nation-wide, electronic image exchange network. We are just getting started.”


“As an advocate for radiology’s critical role in health equity, I am so encouraged by the announcement of this expanded network and its commitment to interoperability,” said Dr. Geraldine McGinty, past President of the ACR. “Patients and physicians alike need an easy way to share images and this is an important first step toward enabling vendors to work together as they should.”


Related Links:
Intelerad Medical Systems 
Life Image 



E-mail Print
FaceBook Twitter Google+ Linked in

Intelerad

Intelerad Medical Systems offers medical imaging PACS and cross-enterprise workflow solutions for imaging providers ranging from imaging centers to large, multi-site healthcare systems. Its solutions increase productivity and streamline workflow by overcoming technical barriers in distributed and complex environments.
More info

More articles about Intelerad

25 Aug 2022
Intelerad Acquires PenRad to Expand Breast Imaging and Lung Screening Capabilities
Intelerad Medical Systems (Raleigh, NC, USA; www), a leading global provider of enterprise medical imaging solutions, has acquired PenRad Technologies, Inc. (Buffalo, MN, USA), a software provider for enhancing productivity for breast imaging and lung screening.
Read More
22 Jun 2019
Intelerad to Invest USD 75 Million in New AI Medical Imaging Offerings
Intelerad Medical Systems, a medical imaging software provider that specializes in diagnostic viewing, reporting and collaboration solutions, has announced a USD 75 million R&D investment towards extending its solutions portfolio.
Read More

Additional news

23 Nov 2022
Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures
The increasing demand for visualization systems for complex surgical procedures, growing demand for minimally invasive surgeries, and rising prevalence of chronic diseases are expected to help the global visualization instruments for minimally invasive surgery (MIS) market register a CAGR of 7.2% between 2022 and 2031 and reach a value of USD 21 billion by 2031.
Read More
11 Nov 2022
Global Diagnostic ECG Market Driven by Increased Incidence of Cardiac Diseases
The rising prevalence of such chronic conditions is necessitating the need for diagnosis and treatment in order to keep track of the patient's daily medical condition and maintain medical records. This, coupled with rising hospitalization of the older population for the treatment of cardiac diseases, has increased the need for electrocardiograph (ECG) diagnosis.
Read More
11 Nov 2022
Radcal to Supply Quality Assurance X-Ray Testing Equipment to West Physics
Radcal Corporation (Monrovia, CA, USA), a leading manufacturer of diagnostic X-ray quality assurance (QA) meters, has reached an agreement with West Physics (Atlanta, GA, USA), one of the largest and most successful Medical Physics groups in the U.S., to supply QA X-ray testing equipment.
Read More
09 Nov 2022
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining panels, tissue staining, and imaging and analysis services.
Read More
08 Nov 2022
Global Infusion Pumps Market Driven by Increasing Incidence of Chronic Diseases
Rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with a rapid growth of the geriatric population, and growing number of surgical procedures being performed, are driving the growth of the global infusion pumps market. As a result, the market is projected to register a CAGR of 7% from USD 14.7 billion in 2022 to USD 20.5 billion by 2027.
Read More
07 Nov 2022
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nan?mix eLab system in the UK, Germany, France, Ireland and South Africa.
Read More
07 Nov 2022
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
An expanded collaboration between two industry leaders will pave the way for the development of AI-enabled diagnostic testing that is more accurate and reliable than current U.S. tests for patients with chronic diseases, including kidney, cardiovascular, liver and neurologic conditions.
Read More
01 Nov 2022
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, driven by an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & non-profit organizations to introduce novel & innovative products to address the growing demand.
Read More
01 Nov 2022
Johnson & Johnson to Acquire Cardiovascular Technology Company Abiomed in USD 16.6 Billion Deal
Johnson & Johnson (New Brunswick, N.J., USA) has entered into a definitive agreement to acquire all outstanding shares of Abiomed, Inc. (Danvers, MA, USA) in a deal valued at approximately USD 16.6 billion which includes cash acquired.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions